7.46
-1.58%
Close of 9 Nov 2026, in EUR
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About Hoenle
Its shares trade on XETRA under the ticker HNL.DE. It has been listed since 25 February 2008. In the fiscal year to 30 September 2025, it reported revenue of €93.7m and a net loss of €3.2m. At that date it held total assets of €145.5m and shareholders' equity of €76.9m.
Dr. Hönle AG engages in the development, manufacture, and sale of light-emitting diode ultraviolet (UV) products. The company is headquartered in Graefelfing, Bayern. The company went IPO on 2008-02-25. The firm develops, manufactures and supplies ultraviolet (UV) equipment. The firm operates three business segments: Equipment and Systems, Adhesives, and Glass and Lamps. The Equipment and Systems segment encompasses the development, production and sale of UV equipment and systems used for drying inks and coatings, for curing adhesives and plastics, disinfecting surfaces and for sunlight simulation. The Adhesives segment comprises the development, production and sale of UV industrial adhesives for the use in the automotive, electronics, medical technology and optics industries, among others. The Glass and Lamps segment includes the development, production and sale of tubing and semi-finished goods made from quartz glass as well as the manufacture of UV medium-pressure and low-pressure lamps. The firm is globally active, with over 69 locations in 27 countries.
Figures and description from our data supplier, not checked against the company's own report.
Company facts
- Sector
- Industrials
- Industry
- Electrical Equipment
- Listed since
- 25 Feb 2008
- Employees
- 601
- Website
- hoenle.de ↗
Leadership
Pay as last reported
- Dr. Bernhard GimpleIndependent Vice Chairman of the Supervisory Board, since 2015€38,000
- Mr. Robert StarkChief Financial Officer, Member of the Management Board
- Dr. Franz RichterMember of the Management Board, since 2023€25.2m
- Mr. Niklas FriedrichsenIndependent Member of the Supervisory Board, since 2022€48,000
- Prof. Dr. Imke LibonIndependent Member of the Supervisory Board€30,000
- Ms. Melanie OttIndependent Member of the Supervisory Board€15,000
- Dipl.-Kfm. Peter WeinertInvestor Relations Manager
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 44
- Environment
- 37
- Social
- 71
- Governance
- 24
- Direct emissions (scope 1)
- 257.22 t
- Energy emissions (scope 2)
- 568.21 t
- Women in the workforce
- 32%
- Carbon reduction policy
- No
- Human rights policy
- Yes
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- Dr Hoenle AG has several notable strengths that contribute to its success in the market. These strengths include:
Weaknesses
- Despite its strengths, Dr Hoenle AG also faces certain weaknesses that need to be addressed in order to maintain its competitive position:
Opportunities
- Despite the weaknesses, Dr Hoenle AG can capitalize on various opportunities in the market:
Threats
- Dr Hoenle AG faces certain threats that can hinder its growth and profitability:
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.